skip to main content

Title: Radiofrequency Ablation Therapy for Solid Tumors

Surgical resection, systemic chemotherapy, and local radiation have been the conventional treatments for localized solid cancer. Because certain patients are not candidates for tumor resection and becmore »ause many tumors are poorly responsive to chemotherapy and radiation, there has been an impetus to develop alternative therapies. Radiofrequency ablation (RFA) is a minimally invasive therapy for localized solid cancers that has gained considerable attention in the last 12 years. Advantages of minimally invasive therapies over surgery include less recovery time, lower morbidity and mortality, eligibility of more patients, and lower cost. RFA has been applied most extensively to inoperable hepatic tumors. It is investigational for tumors in the kidney, lung, bone, breast, and adrenal gland. This colloquium will review the mechanism, techniques, limitations, and clinical applications of RFA. The ultimate role that RFA will play in cancer therapy will depend on the results of long-term follow-up and prospective randomized trials.« less
video
Title: Radiofrequency Ablation Therapy for Solid Tumors
Authors:
Publication Date: 2002-12-04
OSTI Identifier: 1015647
DOE Contract Number: AC02-07CH11359
Other Number(s): TRN: US201209%%72
Resource Type: Multimedia
Resource Relation: Conference: Fermilab Colloquia, Fermi National Accelerator Laboratory (FNAL), Batvia, Illinois (United States), presented on December 04, 2002
Research Org: FNAL (Fermi National Accelerator Laboratory (FNAL), Batavia, IL (United States))
Sponsoring Org: USDOE Office of Science (SC)
Subject: 59 BASIC BIOLOGICAL SCIENCES ; 60 APPLIED LIFE SCIENCES ; ABLATION ; ADRENAL GLANDS ; CHEMOTHERAPY ; DISEASE INCIDENCE ; MORTALITY ; NEOPLASMS ; PATIENTS ; RADIATIONS ; SURGERY ; THERAPY
Country of Publication: United States
Language: English
Run Time: 1:04:28
System Entry Date: 2016-01-27